ScreenerHero

CGC Canopy Growth Corporation

NAS · US · Healthcare · Drug Manufacturers - Specialty & Generic · canopygrowth.com
0.8765USD-1.59%Mkt Cap: 393.81M $P/E: —

Canopy Growth Corporation, together with its subsidiaries, engages in the production, distribution, and sale of cannabis and cannabis-related products for medical and adult use in Canada, Germany, the United States, and …

Industry Peers

Drug Manufacturers - Specialty & Generic
Screen all
MRK
Merck KGaA
$66.23BUSDP/E 25.7
TAK
Takeda Pharmaceutical Company Limited
$58.68BUSD
TEVA
Teva Pharmaceutical Industries Limited
$45.70BUSDP/E 65.3
GALD
Galderma Group AG
$43.27BUSDP/E 56.1
HLN
Haleon plc
$39.67BUSDP/E 18.4
SDZ
Sandoz Group AG
$34.93BUSDP/E 60.5
HLN
Haleon plc
$32.73BUSDP/E 19.0
ZOE
Zoetis Inc.
$28.56BUSDP/E 12.2
ZTS
Zoetis Inc.
$29.57BUSDP/E 11.8
UTHR
United Therapeutics Corporation
$23.38BUSDP/E 19.5
VTRS
Viatris Inc.
$20.09BUSD
SOBI
Swedish Orphan Biovitrum AB (publ)
$14.43BUSDP/E 112.9
NBIX
Neurocrine Biosciences, Inc.
$14.58BUSDP/E 21.0
IPN
Ipsen S.A.
$12.99BUSDP/E 23.5
ELAN
Elanco Animal Health Incorporated
$11.17BUSD
RDY
Dr. Reddy's Laboratories Limited
$10.22BUSDP/E 27.9
KRK
Krka, d. d.
$8.66BUSDP/E 19.3
ALKS
Alkermes plc
$6.95BUSDP/E 109.1
HIMS
Hims & Hers Health, Inc.
$6.89BUSD
AMRX
Amneal Pharmaceuticals, Inc.
$6.84BUSDP/E 40.1

Key Statistics

Company
Market Cap393.81M USD
Enterprise Value316.32M USD
Revenue (TTM)293.63M USD
Gross Profit69.67M USD
Net Income (TTM)-262.91M USD
Revenue/Share0.82 USD
Last Price0.8765 USD
Fiscal Year EndMar 2026
MR QuarterJun 2026
Employees1.1K
CountryUS
SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)-7.47
PEG—
EV/EBITDA-12.12
EV/Revenue1.08
P/S1.36
P/B0.78
EPS (TTM)-0.45
EPS (Forward)-0.12
52W Range
0.84402% of range2.380
52W High2.380 USD
52W Low0.8440 USD
Profitability
Gross Margin24.48%
Oper. Margin-21.66%
EBITDA Margin-8.89%
Profit Margin-92.38%
ROE-37.69%
ROA-23.50%
Growth
Revenue Growth12.50%
Earnings Growth—
Cash Flow & Leverage
Operating CF-63.81M USD
CapEx (TTM)5.95M USD
FCF Margin2.45%
FCF Yield1.83%
Net Debt-60.48M USD
Net Debt/EBITDA2.32
Balance Sheet
Debt/Equity0.40
Current Ratio3.04
Quick Ratio2.28
Book Value/Sh1.14 USD
Cash/Share0.80 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.00 USD
Div. Yield0.00%
5Y Avg Yield—
Payout Ratio—
Ex-Div Date—
Pay Date—
Splits
Last Split1:10
Split DateDec 20, 2023
Analyst Consensus
Rating—
Target (Mean)1.195 USD
Upside (mean)+36.4%
Target Range1.195 USD – 1.195 USD
# Analysts1
Ownership
Shares Out.423.04M
Float422.10M
Insiders0.18%
Institutions7.99%
Short Interest
Short Ratio8.4d
Short % Float6.62%
Short % Out.6.61%
Shares Short27.98M
Short (prev mo.)25.00M
Technical
SMA 500.9593 (-8.6%)
SMA 2001.054 (-16.9%)
Beta2.37
S&P 52W Chg16.45%
Avg Vol (30d)2.72M
Avg Vol (10d)2.36M
Technical Indicators
RSI (14)36.1
MACD-0.0233
MACD Signal-0.0185
MACD Hist.-0.0047
BB Upper0.9783 USD
BB Middle0.9214 USD
BB Lower0.8646 USD
BB Width12.34%
ATR (14)0.0320 USD
Vol Ratio (20d)0.57x